Allotment of 106668 Equity Shares to Promoter upon conversion of warrants into Equity Shares.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has allotted 1,06,668 equity shares to its promoter, Mr. Fredun Nariman Medhora, after he converted part of his warrants. These warrants were originally issued on a preferential basis on December 29, 2025, at a price of Rs. 1,250 per share. The promoter paid the remaining 75% of the consideration (Rs. 937.50 per warrant), bringing in Rs. 10,00,01,250 (about Rs. 10 crore) in total. The face value of each share is Rs. 10, with a premium of Rs. 1,240. Out of the original 1,60,000 warrants, 53,332 are still pending conversion.
The conversion strengthens the promoter's stake and adds about Rs. 10 crore to the company's equity base. This is a sign of the promoter's continued confidence, though it slightly dilutes the holdings of existing public shareholders.